Signal Switching, Crosstalk, and Arrestin Scaffolds
- 1 August 2006
- journal article
- review article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 48 (2) , 173-179
- https://doi.org/10.1161/01.hyp.0000232641.84521.92
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Tackling the EGFR in pathological tissue remodellingPulmonary Pharmacology & Therapeutics, 2006
- Adam Meets Eph: An ADAM Substrate Recognition Module Acts as a Molecular Switch for Ephrin Cleavage In transCell, 2005
- Agonist-Induced Interactions between Angiotensin AT1 and Epidermal Growth Factor ReceptorsMolecular Pharmacology, 2005
- What?s new in the renin-angiotensin system?Cellular and Molecular Life Sciences, 2004
- What?s new in the renin-angiotensin system?Cellular and Molecular Life Sciences, 2004
- Matrix metalloproteinase-dependent EGF receptor activation in hypertension and left ventricular hypertrophyTrends in Endocrinology & Metabolism, 2004
- Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trialThe Lancet, 2003
- Epidermal growth factor receptor: mechanisms of activation and signallingExperimental Cell Research, 2003
- Myocardial-Directed Overexpression of the Human β1-Adrenergic Receptor in Transgenic MiceJournal of Molecular and Cellular Cardiology, 2000
- Mice with a null mutation of the TGFα gene have abnormal skin architecture, wavy hair, and curly whiskers and often develop corneal inflammationCell, 1993